XXXXXXXXX XXXXXXXX XXXXXX (XX) 2023/53
xx xxx 4.&xxxx;xxxxx 2023
x&xxxx;xxxxxxxx přípravku Xxxxxxxxxxx xxxxxxxxxxxx CNCM X-4622&xxxx;xxxx doplňkové xxxxx xxx xxxxxxx xxxxx xxxxxx
(Xxxx x&xxxx;xxxxxxxx xxx XXX)
XXXXXXXX XXXXXX,
x&xxxx;xxxxxxx xx Xxxxxxx x&xxxx;xxxxxxxxx Evropské xxxx,
x&xxxx;xxxxxxx xx nařízení Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1831/2003 ze xxx 22.&xxxx;xxxx&xxxx;2003 x&xxxx;xxxxxxxxxxx xxxxxxx xxxxxxxxxxx xx xxxxxx xxxxxx&xxxx;(1), a zejména xx xx.&xxxx;9 odst. 2 xxxxxxxxx xxxxxxxx,
xxxxxxxx k těmto xxxxxxx:
|
(1) |
Xxxxxxxx (XX) x.&xxxx;1831/2003 xxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxx xx xxxxxx xxxxxx a důvody x&xxxx;xxxxxxx, na xxxxxxx xxxxxxx se povolení xxxxxxx. |
|
(2) |
X&xxxx;xxxxxxx x&xxxx;xx.&xxxx;7 odst. 1 xxxxxxxx (XX) x.&xxxx;1831/2003 xxxx xxxxxx xxxxxx x&xxxx;xxxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxxxx CNCM X-4622. Xxxx xxxxxx byla xxxxxx spolu x&xxxx;xxxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxx podle xx.&xxxx;7 xxxx.&xxxx;3 xxxxxxxx (XX) x.&xxxx;1831/2003. |
|
(3) |
Xxxxxx xx xxxx xxxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxxxx XXXX X-4622&xxxx;xxxx doplňkové xxxxx xxx xxxxxxx xxxxx xxxxxx xx zařazením xx xxxxxxxxx xxxxxxxxxxx xxxxx „xxxxxxxxxxxxx xxxxxxxxx xxxxx“ x&xxxx;xxxxxxxxx skupin „xxxxxxxxxx kyselosti“ x&xxxx;„xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx“. |
|
(4) |
Xxxxxxxx xxxx xxx bezpečnost xxxxxxxx (dále jen „xxxx“) xxxxxx ve xxxx stanovisku xx xxx 29.&xxxx;xxxxxx&xxxx;2022&xxxx;(2) x&xxxx;xxxxxx, xx za navržených xxxxxxxx xxxxxxx xxxx xxxxxxxxx Pediococcus xxxxxxxxxxxx XXXX X-4622 xxxxxxxxxx xxxxxx na zdraví xxxxxx, xxxxxxxxxx xxxxxxxxxxxx xxx xx životní xxxxxxxxx. Xxxxxx xxxxxx x&xxxx;xxxxxx, že je xxxxxxxxx xx xxxxx xxxxxxxxxxxxxxx xxxxxxx xxxxx, xxxxx však xxxx xxxxxxxx xxx xxx/xxxx xxxx látku xxxxxxxxxxxxxxx xxxx. Xxxx dále xxxxxx x&xxxx;xxxxxx, xx xxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx pH a růst xxxxxxxxxxxx xxxxxxxx v tekutých xxxxxxxx. Úřad také xxxxxx xxxxxx x&xxxx;xxxxxxxx xxxxxxx xxxxxxxxx xxxxx xxxxxxx xx krmiv xxxxxxxxxxx xxxxxxxxxx laboratoří, xxxxxxxx xxxxxxxxx (XX) x.&xxxx;1831/2003. |
|
(5) |
X&xxxx;xxxxxxxxx přípravku Pediococcus xxxxxxxxxxxx XXXX X-4622 xxxxxxx, xx podmínky xxx xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx&xxxx;5 xxxxxxxx (XX) x.&xxxx;1831/2003 xxxx xxxxxxx. Xxxxxxxxx xxxxxx přípravku xx proto xxxx xxx xxxxxxxx. Xxxxxx xx xxxxxxx, že xx xxxx xxx xxxxxxx vhodná xxxxxxxx xxxxxxxx, aby xx xxxxxxxxx xxxxxxxxxxx účinkům xx xxxxxx zdraví, xxxxxxx pokud xxx x&xxxx;xxxxxxxxx xxxxxxx xxxxxxxxx xxxxx. |
|
(6) |
Xxxxxxxx xxxxxxxxx xxxxx xxxxxxxxx jsou x&xxxx;xxxxxxx xx xxxxxxxxxxx Stálého xxxxxx pro xxxxxxxx, xxxxxxx, xxxxxxxxx a krmiva, |
PŘIJALA XXXX XXXXXXXX:
Xxxxxx&xxxx;1
1.&xxxx;&xxxx;&xxxx;Xxxxxxxxx uvedený v příloze, xxxxxxxxxx xx xxxxxxxxx xxxxxxxxxxx xxxxx „xxxxxxxxxxxxx xxxxxxxxx xxxxx“ x&xxxx;xxxxxxx xxxxxxx „xxxxxxxxxx kyselosti“, xx povoluje xxxx xxxxxxxxx xxxxx xx xxxxxx xxxxxx podle xxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxx xxxxxxx.
2.&xxxx;&xxxx;&xxxx;Xxxxxxxxx xxxxxxx x&xxxx;xxxxxxx, xxxxxxxxxx xx xxxxxxxxx xxxxxxxxxxx xxxxx „xxxxxxxxxxxxx xxxxxxxxx látky“ a do xxxxxxx xxxxxxx „xxxxx xxxxxxxxxx xxxxxxxxxx podmínky“, xx xxxxxxxx jako xxxxxxxxx xxxxx xx xxxxxx xxxxxx xxxxx xxxxxxxx stanovených v uvedené xxxxxxx.
Xxxxxx&xxxx;2
Xxxx xxxxxxxx xxxxxxxx x&xxxx;xxxxxxxx xxxxxxxx xxxx xx vyhlášení x&xxxx;Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.
Toto xxxxxxxx je xxxxxxx x&xxxx;xxxxx xxxxxxx x&xxxx;xxxxx xxxxxxxxxx xx xxxxx xxxxxxxxx xxxxxxx.
X&xxxx;Xxxxxxx xxx 4.&xxxx;xxxxx 2023.
Za Xxxxxx
xxxxxxxxxxx
Xxxxxx XXX DER XXXXX
(1)&xxxx;&xxxx;Xx.&xxxx;xxxx.&xxxx;X&xxxx;268, 18.10.2003, x.&xxxx;29.
(2)&xxxx;&xxxx;XXXX Xxxxxxx 2022;20(8):7424
XXXXXXX
|
Xxxxxxxxxxxxx číslo xxxxxxxxx xxxxx |
Xxxxxxxxx xxxxx |
Xxxxxxx, xxxxxxxx xxxxxx, xxxxx, xxxxxxxxxx xxxxxx |
Xxxx nebo kategorie xxxxxx |
Xxxxxxxxx xxxxx |
Xxxxxxxxx xxxxx |
Xxxxxxxxx xxxxx |
Xxxxx ustanovení |
Konec xxxxxxxxx xxxxxxxx |
||||||||
|
XXX xxxxxxxxx xxxxx/xx xxxxxxxxxxx krmiva o obsahu xxxxxxxx 12 % |
||||||||||||||||
|
Kategorie: technologické xxxxxxxxx látky. Xxxxxxx xxxxxxx: xxxxxxxxxx xxxxxxxxx. |
||||||||||||||||
|
4x1712 |
Xxxxxxxxxxx xxxxxxxxxxxx CNCM X-4622 |
Xxxxxxx xxxxxxxxx xxxxx: Xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxxxx XXXX X-4622 x&xxxx;xxxxxxx xxxxxxx 1 × 1010 XXX/x Xxxxx xxxxx |
xxxxxxx xxxxx xxxxxx |
–– |
1 x&xxxx;109 |
–– |
|
24.1.2033 |
||||||||
|
Xxxxxxxxxxxxxxx xxxxxx xxxxx Xxxxxxx buňky Xxxxxxxxxxx xxxxxxxxxxxx XXXX X-4622 |
||||||||||||||||
|
Xxxxxxxxxx xxxxxx (1) Xxxxxxxxx xxxxx xxxxxxxxxxxxxx: xxxxxx xxxxxxxxx xx xxxxx XXX (XX 15786) Identifikace: xxxxxx xxxxxxxxxxxxx x&xxxx;xxxxxxx xxxxx (XXXX) nebo xxxxxx xxxxxxxxxxx XXX |
||||||||||||||||
|
Xxxxxxxxxxxxx číslo xxxxxxxxx xxxxx |
Xxxxxxxxx xxxxx |
Xxxxxxx, xxxxxxxx xxxxxx, popis, xxxxxxxxxx metoda |
Druh xxxx xxxxxxxxx xxxxxx |
Xxxxxxxxx xxxxx |
Xxxxxxxxx xxxxx |
Xxxxxxxxx xxxxx |
Xxxxx xxxxxxxxxx |
Xxxxx xxxxxxxxx xxxxxxxx |
||||||||
|
XXX xxxxxxxxx xxxxx/xx xxxxxxxxx xxxxxxxxx |
||||||||||||||||
|
Xxxxxxxxx: xxxxxxxxxxxxx xxxxxxxxx xxxxx. Xxxxxxx xxxxxxx: látky xxxxxxxxxx xxxxxxxxxx xxxxxxxx (xxxxxxx xxxxx xxxxxxxxxxxx xxxxxxxx). |
||||||||||||||||
|
4x1712 |
Xxxxxxxxxxx acidilactici XXXX X-4622 |
Xxxxxxx xxxxxxxxx xxxxx: Xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxxxx XXXX X-4622 x&xxxx;xxxxxxx nejméně 1 × 1010 XXX/x Xxxxx xxxxx |
xxxxxxx xxxxx xxxxxx |
–– |
1 x 109 |
–– |
|
24.1.2033 |
||||||||
|
Xxxxxxxxxxxxxxx xxxxxx látky Vitální buňky Xxxxxxxxxxx xxxxxxxxxxxx XXXX X-4622 |
||||||||||||||||
|
Xxxxxxxxxx metoda (2) Xxxxxxxxx xxxxx xxxxxxxxxxxxxx: xxxxxx xxxxxxxxx xx agaru XXX (XX 15786) Identifikace: xxxxxx xxxxxxxxxxxxx x&xxxx;xxxxxxx xxxxx (XXXX) nebo xxxxxx xxxxxxxxxxx DNA |
||||||||||||||||
(1) Podrobné xxxxxxxxx o analytických xxxxxxxx xxx xxxxxx na xxxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx: xxxxx://xxxxx-xxxxxxxx-xxxxxx.xx.xxxxxx.xx/xxxx-xx-xxxx-xxxx-xxxxxxxxx/xxxx-xx-xxxxxxxxxxxxx/xxxx-xx-xxxxxxxxxx-xxxxxxx_xx
(2)&xxxx;&xxxx;Xxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxxxx metodách xxx xxxxxx xx internetové xxxxxxx xxxxxxxxxx xxxxxxxxxx: xxxxx://xxxxx-xxxxxxxx-xxxxxx.xx.xxxxxx.xx/xxxx-xx-xxxx-xxxx-xxxxxxxxx/xxxx-xx-xxxxxxxxxxxxx/xxxx-xx-xxxxxxxxxx-xxxxxxx_xx